DE
WST icon

DV Equities’s West Pharmaceutical WST Stock Holding History

DV Equities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$27.5K Buy
+100
New +$27.4K ﹤0.01% 484

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

DV Equities's WST Position: Q4 2025 in Review

DV Equities opened a new position in West Pharmaceutical (WST) in Q4 2025: 100 shares worth $27.5K. The stake represents ﹤0.01% of the portfolio and ranks #484 among its holdings.

804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • DV Equities held 100 shares of West Pharmaceutical worth $27.5K as of Q4 2025.
  • West Pharmaceutical was a new DV Equities position in Q4 2025.
  • West Pharmaceutical made up ﹤0.01% of DV Equities's portfolio in Q4 2025, its #484 holding.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.